Ananthakrishnan Ganesan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ananthakrishnan Ganesan

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Cell Reports. Medicine|December 10, 2024

Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disordersJiaying Toh, Andrea J Reitsma, Tetsuya Tajima, et al.

Nature Medicine|October 1, 2025

A consensus immune dysregulation framework for sepsis and critical illnessesAndrew R Moore, Hong Zheng, Ananthakrishnan Ganesan, et al.

Nature Medicine|October 28, 2025

Author Correction: A consensus immune dysregulation framework for sepsis and critical illnessesAndrew R Moore, Hong Zheng, Ananthakrishnan Ganesan, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Cell Reports. Medicine|December 10, 2024

Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disordersJiaying Toh, Andrea J Reitsma, Tetsuya Tajima, et al.

Nature Medicine|October 1, 2025

A consensus immune dysregulation framework for sepsis and critical illnessesAndrew R Moore, Hong Zheng, Ananthakrishnan Ganesan, et al.

Nature Medicine|October 28, 2025

Author Correction: A consensus immune dysregulation framework for sepsis and critical illnessesAndrew R Moore, Hong Zheng, Ananthakrishnan Ganesan, et al.

Pageof 2